Anzeige
Mehr »
Dienstag, 15.09.2026 - Börsentäglich über 12.000 News
80,4 g/t Gold und 131 g/t Silber: Was, wenn die alten Minen erst der Anfang waren?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DL7T | ISIN: SE0017769995 | Ticker-Symbol: BGLA
Tradegate
15.09.26 | 10:43
9,520 Euro
-0,26 % -0,025
1-Jahres-Chart
BIOGAIA AB Chart 1 Jahr
5-Tage-Chart
BIOGAIA AB 5-Tage-Chart
RealtimeGeldBriefZeit
9,4659,59523:01
9,4709,56522:00

Aktuelle News zur BIOGAIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBioGaia AB will launch a new clinically proven probiotic to support colon health446BioGaia announces the launch of BioGaia® Colus®, a probiotic formulation designed to promote colon health through a strain-specific and targeted delivery approach. The product expands BioGaia's science-based...
► Artikel lesen
31.08.BioGaia AB: BioGaia and Recordati strengthen their partnership in Spain and Portugal406BioGaia AB has signed a new long-term exclusive distribution agreement with Recordati for Spain and Portugal, building on the companies' existing collaboration in the Iberian market and partnership...
► Artikel lesen
26.08.BioGaia steigert Gewinn deutlich - Produkte für Erwachsene laufen stark4
BIOGAIA Aktie jetzt für 0€ handeln
17.07.BioGaia AB (publ) GAAP EPS of SEK 1.02, revenue of SEK 440.9M1
17.07.BioGaia AB Ser. B Q2 Income Advances1
17.07.BioGaia Q2 2026 slides: 12% organic growth, margins reach 33%1
17.07.BioGaia AB: Interim Report January - June 2026328SECOND QUARTER 2026 Net sales amounted to SEK 440.9 million (404.7), an increase of SEK 36.2 million, an increase excluding currency effects of 12% (9% including currency effects). Net sales in the...
► Artikel lesen
02.07.Invitation to media and analyst briefing for BioGaia Q2 2026 report2
18.06.BioGaia AB's subsidiary introduces a complete skincare routine for babies and children514BioGaia AB's subsidiary, Biogaia New Sciences AB, is expanding its BioGaia® Skincare portfolio with two new products and an updated design across the full range. The expanded skincare line reinforces...
► Artikel lesen
11.05.Probiotika-Aktie BioGaia nähert sich Allzeithoch2
08.05.Dividendenbekanntmachungen (08.05.2026)17.010 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADDNODE GROUP AB  SE0017885767  1,15 SEK  0,1057 EUR  ADIDAS AG  DE000A1EWWW0 - 2,8 EUR  ALLIANCE RESOURCE PARTNERS LP  US01877R1086  0...
► Artikel lesen
07.05.BioGaia AB: Bulletin from Annual General Meeting of BioGaia AB (publ)291The Annual General Meeting of BioGaia AB (publ) was held on 7 May 2026 at 4.00 pm at Klara Konferens & Happynings, Klarabergsviadukten 90, Stockholm, at which the shareholders passed the resolutions...
► Artikel lesen
07.05.BioGaia AB Ser. B Reveals Drop In Q1 Income2
07.05.BioGaia AB launches BioGaia Protectis Plus - next-generation patented probiotic drops2
07.05.BioGaia AB: Interim Management Statement January - March 2026365FIRST QUARTER 2026 Net sales amounted to SEK 372.6 million (366.3), an increase of SEK 6.3 million, an increase excluding currency effects of 15% (2% including currency effects). Net sales in the...
► Artikel lesen
30.04.Invitation to media and analyst briefing for BioGaia Q1 2026 report2
28.04.BioGaia AB research confirms effectiveness of patented LongevityGuard technology in extending probiotic shelf life472Researchers at BioGaia have published new scientific findings in the journal Food and Bioprocess Technology, demonstrating that BioGaia's patented LongevityGuard® technology significantly improves the...
► Artikel lesen
30.03.Notice to attend the Annual General Meeting of BioGaia AB (publ)1
30.03.BioGaia Annual and Sustainability Report 2025 published3
20.03.BIOGAIA: 10-year follow-up study shows infant probiotics are positively associated with a reduction of childhood functional abdominal pain2
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1